Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

New findings may help diagnose and understand scarring alopecia better.

Finasteride does not prevent bladder cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Androgens may influence bladder cancer progression by affecting cellular behavior.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

A group has developed therapies that show promise for treating cancer and various other conditions.